These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8401536)

  • 1. Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE).
    Smith-Sørensen B; Gebhardt MC; Kloen P; McIntyre J; Aguilar F; Cerutti P; Børresen AL
    Hum Mutat; 1993; 2(4):274-85. PubMed ID: 8401536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
    Andersen TI; Eiken HG; Couch F; Kaada G; Skrede M; Johnsen H; Aloysius TA; Tveit KM; Tranebjaerg L; Dørum A; Møller P; Weber BL; Børresen-Dale AL
    Hum Mutat; 1998; 11(2):166-74. PubMed ID: 9482581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
    Børresen AL; Hovig E; Smith-Sørensen B; Malkin D; Lystad S; Andersen TI; Nesland JM; Isselbacher KJ; Friend SH
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8405-9. PubMed ID: 1924299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE).
    Smith-Sørensen B; Hovig E; Andersson B; Børresen AL
    Mutat Res; 1992 Sep; 269(1):41-53. PubMed ID: 1381470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism.
    O'Connell CD; Tian J; Juhasz A; Wenz HM; Atha DH
    Electrophoresis; 1998 Feb; 19(2):164-71. PubMed ID: 9548275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.
    Högmo A; Börresen-Dale AL; Blegen H; Lindholm J; Kuylenstierna R; Auer G; Munck-Wikland E
    Anticancer Res; 1999; 19(4C):3433-8. PubMed ID: 10629631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.
    Holmila R; Husgafvel-Pursiainen K
    Cancer Detect Prev; 2006; 30(1):1-6. PubMed ID: 16458448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
    Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques.
    Condie A; Eeles R; Borresen AL; Coles C; Cooper C; Prosser J
    Hum Mutat; 1993; 2(1):58-66. PubMed ID: 8477265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
    McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
    J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of p53 point mutations by dideoxyfingerprinting (ddF).
    Martincic D; Whitlock JA
    Oncogene; 1996 Nov; 13(9):2039-44. PubMed ID: 8934553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias.
    Pignon JM; Vinatier I; Fanen P; Jonveaux P; Tournilhac O; Imbert M; Rochant H; Goossens M
    Hum Mutat; 1994; 3(2):126-32. PubMed ID: 8199593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
    Greiner TC
    Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.